All Articles

A proposed year-round sightseeing tram near Glacier National Park tests the balance between accessible tourism, economic growth, and wilderness preservation.

As a critical FDA decision looms for its lead drug, Hansa Biopharma partners with Cradle to build a sustainable, AI-driven autoimmune discovery engine.

As EU aviation mandates tighten, Uniper's capacity reservation for Syzygy’s light-driven SAF platform signals a strategic pivot toward Latin American supply.

As data centers drain the grid, Apollo and GDEV are quietly consolidating rural run-of-river hydro to secure clean, reliable baseload power.

With over 700,000 annual deaths, liver cancer is a global crisis. Yet 60% of cases are preventable. We explore the gap between innovation and patient access.

HoneyNaps is transforming clinical trials by turning its FDA-cleared AI diagnostic software into a specialized Contract Research Organization for sleep data.

Rakovina Therapeutics is teaming up with Celvion to leverage real-world AI data, aiming to bypass clinical hurdles and de-risk its ATR inhibitor pipeline.

As the 2026 Paris Motor Show kicks off, a Chinese tech giant is rewriting the playbook, challenging Tesla on autonomy while building cars and robots in Europe.

As electrical grids struggle with megawatt-scale charging, a new off-grid hydrogen field lab in Rotterdam offers a heavy-lifting alternative for port logistics.

As InCorp rebrands to Ascentium Singapore, a massive consolidation wave reveals a shift from back-office compliance to human-centric growth ecosystems.

AI delivers undeniable ROI, yet only 13% of organizations successfully scale it. Discover the hidden workforce and regulatory costs stalling progress.

By appointing Dr. Rajesh Chopra as CSO, Swiss biotech Numab Therapeutics signals a strategic pivot toward clinical execution for its trispecific IBD pipeline.

As trade barriers rise, Chinese automaker Chery deploys its futuristic OMODA X to capture European youth and redefine the global crossover market.

Dunbar Pharmaceuticals has launched the UK’s first plant-derived dronabinol oral spray, signaling a major shift in European biopharma infrastructure.

As GLP-1 drugs face scrutiny for causing lean tissue loss, advanced MRI biomarkers are reshaping clinical trials and the future of metabolic medicine.

By swapping restrictive public bonds for a flexible insider-backed debt and equity package, Gentoo Media secures its future at the cost of heavy dilution.

Gentoo Media's eleventh-hour refinancing deal escapes a Nordic bond trap, but the Juroszek family's massive premium backstop signals a ruthless consolidation of corporate control.

Kyocera's new KMH Series thermal printhead solves a critical friction point in sub-zero logistics, proving niche engineering drives B2B profitability.

Private equity firm Investcorp brings in former Tech Mahindra executive Kunal Purohit to scale NuSummit's AI and cybersecurity offerings in the BFSI sector.

Constellation Software’s Volaris Group offers a 31% premium to acquire Swedish SaaS provider Triona, testing new Nordic FDI infrastructure rules.